SCHEMBL22033474

SCHEMBL22033474

CCCCCCCCC(=O)C1(C(=O)O)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.50
PPARG P37231 7/20 0.50
PPARD Q03181 7/20 0.50
PPARA Q07869 7/20 0.50
HDAC11 Q96DB2 5/20 0.50
TSHR P16473 5/20 0.50
PTPN1 P18031 3/20 0.50
ALDH1A1 P00352 3/20 0.50
TLR2 O60603 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
FABP4 P15090 2/20 0.50
KMT2A Q03164 2/20 0.50
SLC22A6 Q4U2R8 1/20 0.50
SLC22A8 Q8TCC7 1/20 0.50
MEN1 O00255 1/20 0.50
ESR1 P03372 1/20 0.50
ALOX15 P16050 1/20 0.50
PDE4A P27815 1/20 0.50
PDE3A Q14432 1/20 0.50
HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17451245 0.91 GPR84 (0.45) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7233038 0.82 CES2 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3176238 0.82 CES2 (0.44) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL6059684 0.79 TSHR (0.44) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL6059711 0.79 TSHR (0.44) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL22033617 0.78 FAAH (0.45) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL16156040 0.75 CES2 (0.50) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL18660405 0.74 KMT2A (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL5707832 0.73 CES2 (0.48) GPR84PPARGPPARDPPARAHDAC11
Undecanoate SCHEMBL11859217 0.71 GPR84 (0.94) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250074866-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2025-03-06 US disclosed
CN-119285480-A Modified amine lipids 英特利亚治疗股份有限公司 2025-01-10 CN disclosed
US-12077483-B2 Modified amine lipids INTELLIA THERAPEUTICS, INC. (US) 2024-09-03 US disclosed
US-20220119341-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2022-04-21 US disclosed
US-20220119341-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. 2022-04-21 US disclosed
EP-3891127-A1 MODIFIED AMINE LIPIDS Intellia Therapeutics, Inc. (US) 2021-10-13 EP disclosed
CN-113260607-A Modified amine lipids 英特利亚治疗股份有限公司 2021-08-13 CN disclosed
WO-2020118041-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-06-11 WO disclosed
WO-2020118041-A1 MODIFIED AMINE LIPIDS INTELLIA THERAPEUTICS, INC. (US) 2020-06-11 WO disclosed
CN-101472892-A Organic compounds NOVARTIS AG (CH) 2009-07-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12077483-B2 Modified amine lipids PHOSPHO1, SGMS1, SGMS2 GPR84 1948/4885PPARG 1811/4885PPARD 2143/4885
US-20220119341-A1 MODIFIED AMINE LIPIDS PHOSPHO1, SGMS1, SGMS2 GPR84 1948/4885PPARG 1811/4885PPARD 2143/4885
US-20250074866-A1 MODIFIED AMINE LIPIDS PHOSPHO1, SGMS1, SGMS2 GPR84 1948/4885PPARG 1811/4885PPARD 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.